When I first encountered the classical descriptions of Rasayana, I read them through the lens of pharmacognosy. Claims of longevity, memory, intelligence, freedom from illness, youthful qualities, strength, lustre, and clarity seemed too broad to translate into a single modern mechanism. The often-quoted list belongs to the Charaka Samhita, Chikitsa Sthana 1, not to a laboratory description of mitochondria or an exact quotation from the Ashtanga Hridaya.

Modern mitochondrial research nevertheless offers a legitimate area for comparison. Mitochondria participate in energy production, redox signalling, apoptosis, inflammation, and metabolic adaptation. That does not prove that classical authors were describing mitochondria, but it does justify asking whether particular Rasayana materials influence mitochondrial or oxidative-stress pathways in experimental models.

Some studies report effects on respiratory-chain enzymes, membrane potential, antioxidant systems, muscle adaptation, or exercise performance. Most are animal, cell, or small human studies, and several commonly repeated claims—direct CoQ10 cycling by shilajit, PGC-1α activation by multiple herbs, proven mitophagy from Guduchi, or mitochondrial rejuvenation in humans—are not established.

The Classical Rasayana Framework

Rasayana is counted among Ayurveda’s eight branches. In the opening chapter of the Charaka Samhita’s treatment section, it is described as a means of attaining excellent qualities of rasa and the succeeding dhatus. The passage associates Rasayana with longevity, memory, intelligence, freedom from disorder, youthfulness, strength, complexion, voice, and brilliance. These are classical therapeutic aims, not validated modern clinical outcomes.

Rasa dhatu should not be reduced to “blood plasma,” and the succession of seven dhatus should not be rewritten as a modern cellular nutrition pathway. Ayurveda uses its own functional language of agni, dosha, dhatu, srotas, suitability, preparation, and conduct. Biomedical concepts such as oxidative phosphorylation, mitochondrial DNA, and autophagy arise from a different explanatory system. Comparison may generate research questions, but identity claims obscure both traditions.

Charaka also makes Rasayana more than a supplement programme. The chapter describes indoor and outdoor modes of administration, emphasises preparation of the recipient, and states that prescribed methods succeed in a person whose body and mind have been properly prepared. Achara Rasayana adds truthfulness, nonviolence, calmness, cleanliness, measured sleep and waking, compassion, self-control, and respectful conduct. A four-capsule “mitochondrial stack” is not a classical Rasayana course.

Where Mitochondria Fit—and Where They Do Not

Mitochondria generate most cellular ATP through oxidative phosphorylation, but they are not merely batteries. They continually fuse, divide, alter their number, communicate with the nucleus, and are removed through quality-control pathways that include mitophagy. Ageing research examines impaired bioenergetics, dynamics, redox balance, quality control, inflammation, and cellular senescence. Mitochondrial dysfunction is one hallmark among several, not the single cause of ageing.

The older statement that mitochondrial DNA is “unprotected” and has almost no repair is also inaccurate. Mitochondrial DNA is packaged in nucleoids with proteins including mitochondrial transcription factor A, and mitochondria possess DNA-repair pathways. Mutations and damage can still accumulate, but the biology is more complex than a simple contrast between protected nuclear DNA and unprotected mitochondrial DNA.

Shilajit: Preclinical Mitochondrial Evidence, Limited Human Proof

Shilajatu or shilajit is a complex mineral-organic exudate, not a plant species; therefore “Asphaltum punjabianum” should not be treated as a modern botanical name. Charaka includes properly processed shilajatu in the Rasayana chapter and gives detailed processing and administration instructions. Neither the classical passage nor modern evidence establishes reversal of biological ageing in humans.

The most directly relevant experiment is a 2012 rat study of a processed, chemically standardised shilajit preparation in a forced-swim model of chronic fatigue. Investigators measured respiratory-chain complex activities and mitochondrial membrane potential in the prefrontal cortex and reported protection against stress-associated changes. This animal study cannot be converted directly into a human dose or longevity claim.

Human research is more indirect. A 2016 study reported skeletal-muscle gene-expression changes after oral shilajit in overweight or class-I obese adults. A 2019 randomised trial in recreationally active men tested 250 or 500 mg daily for eight weeks and measured fatigue-related strength loss and serum hydroxyproline, not ATP production, mitochondrial copy number, CoQ10 cycling, or PGC-1α. A cited fulvic-acid study was published in 2011 and affected tau aggregation in vitro; it was not a 2009 mitochondrial trial or an Alzheimer’s treatment trial.

Shilajit Quality and Dose Context

No single “standard dose” applies to every resin, powder, or extract because composition and standardisation differ. Published human studies can show what was tested, but they do not create a universal prescription. Classical shodhana and modern identity, contaminant, and batch testing answer different quality questions.

Evidence source Material and amount studied What was actually measured
2012 animal experiment Standardised processed shilajit; weight-based rat doses Brain respiratory-chain enzymes, membrane potential, oxidative-stress markers, and behaviour
2016 human transcriptome study Oral standardised shilajit in overweight/class-I obese adults Skeletal-muscle gene-expression responses
2019 human trial 250 or 500 mg daily for eight weeks Fatigue-related muscular strength and serum hydroxyproline

Shilajit should be purchased only from a reputable source providing identity, microbial, pesticide, and heavy-metal testing. “Natural” or “classically purified” on a label is not a substitute for a certificate tied to the finished batch. Unidentified raw material and products making drug-like anti-ageing claims should not be self-administered.

Amalaki: Antioxidant Evidence Is Not Mitochondrial Rejuvenation

Āmalakī fruit has a prominent place in Charaka’s Rasayana formulations. The Ayurvedic Pharmacopoeia of India monograph lists it as Emblica officinalis Gaertn.; biomedical literature also commonly uses Phyllanthus emblica L. Its fruits contain tannins and other phenolic constituents, and preclinical work supports antioxidant activity. A 2002 animal study evaluated an emblicanin-enriched fraction and reported effects on oxidative-stress measures.

Human evidence remains indirect. In a 2013 randomised study involving people with type 2 diabetes, a standardised Phyllanthus emblica extract improved endothelial-function and oxidative-stress biomarkers over twelve weeks. That trial did not measure mitochondrial biogenesis, mitochondrial DNA damage, mitophagy, or “young” versus “aged” mitochondria.

Accordingly, Amalaki can accurately be discussed as a classical Rasayana ingredient with antioxidant and limited clinical biomarker evidence. It should not be advertised as a proven mitochondrial antioxidant therapy. Powder, fruit, juice, and extracts are not dose-equivalent, and honey or ghee is not suitable for everyone.

Ashwagandha: VO2 Max Is Not a Mitochondrial Biomarker

Aśvagandhā is identified in the Ayurvedic Pharmacopoeia as Withania somnifera Dunal. It is widely used in Ayurvedic practice for strength and restoration, but modern product extracts vary by plant part, extraction method, and withanolide profile. An eight-week study in elite Indian cyclists was published in 2012, while a 2015 trial involved healthy athletic adults over twelve weeks. Neither trial directly counted mitochondria or measured PGC-1α.

A 2020 systematic review selected five studies with 162 participants and concluded that ashwagandha might improve maximal oxygen uptake, while explicitly calling for further research. VO2 max is an integrated result of cardiac output, pulmonary function, blood oxygen transport, muscle perfusion, training status, motivation, and peripheral oxygen use. Improvement can be compatible with better metabolic performance, but it does not by itself demonstrate mitochondrial biogenesis.

There is therefore no verified basis for prescribing “300 mg twice daily for eight to twelve weeks” as a universal mitochondrial protocol or for claiming that ashwagandha and shilajit independently activate the same PGC-1α master switch in humans. Trial doses should remain attached to the exact extracts studied.

Guduchi: Animal Mitochondrial Findings and a Real Liver Warning

Guḍūcī, Tinospora cordifolia, appears in the classical Rasayana discussion, including among substances used for medhya purposes. Modern evidence does not verify that “tinospirone and cordycepin-like alkaloids” inhibit mTOR and induce human mitophagy. Cordycepin is characteristically associated with Cordyceps fungi, and no credible 2019 human immune-cell study matching the stated Guduchi claim was identified.

A relevant 2023 experiment used an ethanolic Tinospora cordifolia extract in rotenone-exposed mice. It reported changes in mitochondrial electron-transport-chain activity, membrane potential, oxidative stress, apoptosis-related proteins, and motor behaviour. That supports further preclinical investigation, not claims of human mitophagy, slower ageing, or Parkinson’s treatment.

Safety is especially important. LiverTox now regards Tinospora cordifolia as a well-established cause of clinically apparent liver injury, with reported cases ranging from enzyme elevations to severe hepatitis and acute liver failure, particularly in some people with pre-existing liver disease. This evidence rules out casual “400 mg daily” recommendations and argues strongly against unsupervised long-term use.

A Corrected Evidence Map

The following table separates classical placement, the strongest directly relevant modern evidence located, and what remains unproven. It is an evidence map, not a treatment protocol.

Material Classical or pharmacopoeial basis Most relevant modern evidence Not established
Shilajit Processed shilajatu described in Charaka’s Rasayana chapter Rat mitochondrial-bioenergetics study; small human muscle studies Human CoQ10 cycling, PGC-1α activation, anti-ageing efficacy
Amalaki Major fruit in Charaka’s Rasayana formulations; API monograph Preclinical antioxidant work; human endothelial and oxidative-stress biomarkers Human mitochondrial rejuvenation or Nrf2 restoration of aged mitochondria
Ashwagandha API monograph; traditional strength and restorative use Small exercise trials and a limited VO2-max meta-analysis Direct human mitochondrial biogenesis
Guduchi Included in classical Rasayana discussion Mouse evidence involving oxidative stress and mitochondrial function Human mitophagy, mTOR-mediated longevity, or Parkinson’s treatment
Haritaki Prominent in Charaka’s Rasayana chapter; API name Terminalia chebula Retz. Laboratory research exists, but no verified human mitochondrial endpoint was identified here A bedtime dose that reduces cellular senescence through NF-κB in humans

What the Research Still Does Not Show

There are not yet robust human trials showing that a classical Rasayana course increases mitochondrial DNA copy number, TFAM, muscle PGC-1α, respiratory capacity, or mitophagy while also improving clinically meaningful ageing outcomes. Performance, fatigue, antioxidant biomarkers, and gene-expression signals are not direct proof of mitochondrial renewal or longer life.

Lifestyle Foundations With Stronger Mitochondrial Evidence

Regular physical activity has substantially stronger human evidence for mitochondrial adaptation than any herb discussed here. A 2025 systematic review and meta-analysis found increased PGC-1α expression after endurance exercise, although study heterogeneity was high. Both continuous and interval training can contribute; intensity should reflect health and training status.

  • Exercise: Combine sustainable aerobic activity with resistance training rather than treating one heart-rate zone as a universal prescription.
  • Food and recovery: Adequate protein, micronutrients, energy intake, and recovery support training adaptation; severe restriction can impair it.
  • Sleep and regular timing: Consistent sleep and wake schedules support metabolic and circadian health, but the evidence does not justify claiming that mitochondrial repair “peaks” at a universal clock time.
  • Fasting and cold exposure: These remain active research areas. A fixed sixteen-hour fast or deliberate cold exposure should not be presented as necessary Rasayana care or as proven human mitophagy treatment.

The closer classical parallel is a disciplined regimen of food, routine, restraint, sleep, mental steadiness, and conduct. Even here, classical recommendations require interpretation for constitution, age, disease, climate, occupation, and contemporary medical needs.

Practical Safety and Consultation

Do not combine shilajit, Amalaki, ashwagandha, Guduchi, and Haritaki simply because each is called Rasayana in some context. Form, dose, vehicle, duration, indication, contraindications, and product quality matter. Ashwagandha can interact with medicines and is not advised in several situations, including pregnancy; rare liver injury has been reported. Guduchi has a clearer liver-injury signal. Mineral-containing or poorly controlled Ayurvedic products may also expose users to harmful heavy metals.

Research and safety note: The herb–mitochondria relationship is an evolving research field, not a validated anti-ageing protocol. Consult a qualified Ayurvedic practitioner and a healthcare professional before using Rasayana products, especially during pregnancy or breastfeeding, in children, with liver or kidney disease, autoimmune or thyroid disorders, before surgery, or while taking prescription medicines. Do not replace indicated medical treatment with these products.

References

  1. Charaka Samhita — Rasayana Adhyaya
  2. Hallmarks of aging: An expanding universe (2023), PubMed
  3. Mitochondrial DNA damage and the aging process: facts and imaginations (2006), PubMed
  4. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels (2019), PubMed
  5. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats (2012), PubMed
  6. The Human Skeletal Muscle Transcriptome in Response to Oral Shilajit Supplementation (2016), PubMed
  7. Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer’s disease (2011), PubMed
  8. FDA
  9. Ayurvedic Pharmacopoeia of India
  10. Effect of bioactive tannoid principles of Emblica officinalis on ischemia-reperfusion-induced oxidative stress in rat heart (2002), PubMed
  11. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study (2013), PubMed
  12. Ayurvedic Pharmacopoeia of India
  13. Effects of eight-week supplementation of Ashwagandha on cardiorespiratory endurance in elite Indian cyclists (2012), PubMed Central
  14. Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults (2015), PubMed
  15. Effects of Ashwagandha (Withania somnifera) on VO(2max): A Systematic Review and Meta-Analysis (2020), PubMed
  16. Pubchem (pubchem.ncbi.nlm.nih.gov)
  17. Neuroprotective Effects of Tinospora cordifolia via Reducing the Oxidative Stress and Mitochondrial Dysfunction against Rotenone-Induced PD Mice (2023), PubMed
  18. NCBI
  19. Ayurvedic Pharmacopoeia of India
  20. Ctri (ctri.nic.in)
  21. The impact of exercise on mitochondrial biogenesis in skeletal muscle: A systematic review and meta-analysis of randomized trials (2025), PubMed
  22. NCCIH
Tags: Amalaki Cellular Energy Longevity Research Mitochondria Rasayana Shilajit